1,210
Participants
Start Date
June 6, 2019
Primary Completion Date
March 31, 2042
Study Completion Date
March 31, 2042
Acetylsalicylic acid
100mg
Atorvastatin
80 mg
WITHDRAWN
Kantonsspital Baselland, Bruderholz
WITHDRAWN
Klinik Hirslanden Aarau, Aarau
WITHDRAWN
Kantonsspital Baden, Baden
ACTIVE_NOT_RECRUITING
Bellinzona Istituto Oncologico, Bellinzona
ACTIVE_NOT_RECRUITING
Kantansspital Graubündern, Chur
WITHDRAWN
Stadtspital Triemli, Zurich
WITHDRAWN
Kantonsspital Münsterlingen, Münsterlingen
ACTIVE_NOT_RECRUITING
Kantonsspital St.Gallen, Sankt Gallen
RECRUITING
CHU Besançon Hopital Jean Minjoz, Besançon
RECRUITING
Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez
RECRUITING
Institut Jean Godinot, Reims
RECRUITING
Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy
RECRUITING
Centre Jean Perrin, Clermont-Ferrand
RECRUITING
Hôpital de la Croix Saint Simon, Paris
RECRUITING
Hôpital Foch, Suresnes
RECRUITING
Hôpital d'Instruction des Armées Bégin, Saint-Mandé
RECRUITING
Gustave Roussy Cancer Campus Grand Paris, Villejuif
NOT_YET_RECRUITING
Studentova, Olomouc
NOT_YET_RECRUITING
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan
NOT_YET_RECRUITING
NOVOTNA, Bratislava
NOT_YET_RECRUITING
AYADI, Tunis
RECRUITING
Centre Azuréen de Cancérologie, Mougins
RECRUITING
Centre Antoine Lacassagne, Nice
National Cancer Institute, France
OTHER_GOV
Gustave Roussy, Cancer Campus, Grand Paris
OTHER